Real-world use of an artificial intelligence–powered clinical decision support tool for ovarian stimulation
Physician use of AI helped significantly reduce the starting and total FSH doses prescribed to patients without adversely affecting MII outcomes, indicating the potential use of AI in lowering in vitro fertilization costs to patients.
Authors
- Bradley A. Miller (ORCID: https://orcid.org/0000-0001-8194-123X)
- Cameron J Bixby
Institutions
- Providence Hospital (US)
- Reproductive Medicine Associates of New York (US)
- Michigan Reproductive Medicine (US)
- Providence Hospital (US)
- Reproductive Biology Associates (US)
Publication Details
- Journal
- F&S Reports
- Published
- 2025-01-28
- DOI
- https://doi.org/10.1016/j.xfre.2025.01.015
- Citations
- 3
- Primary Topic
- Insurance, Mortality, Demography, Risk Management
- Type
- article
- Field-Weighted Citation Impact
- 16.78